During the past decade, Marin General Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 29 clinical trials were completed, i.e. on average, 138.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 12 clinical trials were completed. i.e. 240% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marin General Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 28 trials, followed by "NRG Oncology" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "SWOG Cancer Research Network" with 3 trials sponsored and "AirXpanders, Inc." with 3 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marin General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 22 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator and "North Central Cancer Treatment Group" with 5 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Marin General Hospital" are "Recurrent Breast Carcinoma" (5 trials), "Prostate Adenocarcinoma" (4 trials), "Breast Adenocarcinoma" (3 trials), "Colorectal Cancer" (3 trials) and "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials). Many other conditions were trialed in "Marin General Hospital" in a lesser frequency.

Most popular intervention types in "Marin General Hospital" are "Drug" (47 trials), "Other" (36 trials), "Biological" (23 trials), "Radiation" (18 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (27 trials), "Quality-of-Life Assessment" (14 trials), "Bevacizumab" (13 trials), "Paclitaxel" (8 trials) and "Radiation Therapy" (6 trials). Other intervention names were less common.

The vast majority of trials in "Marin General Hospital" are 38 trials for "All" genders, 9 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Marin General Hospital". undefined are not yet recruiting, 7 are recruiting, 30 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Marin General Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Marin General Hospital, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".

Marin General Hospital has several departments that took part in Clinical trials: "Marin Cancer Institute at Marin General Hospital" - 24 trials